Free Trial

Livforsakringsbolaget Skandia Omsesidigt Increases Stake in HCA Healthcare, Inc. $HCA

HCA Healthcare logo with Medical background

Key Points

  • Livforsakringsbolaget Skandia Omsesidigt increased its holdings in HCA Healthcare by 27.9%, owning 21,999 shares worth approximately $8.42 million after acquiring an additional 4,800 shares in Q2.
  • HCA Healthcare's quarterly earnings report revealed an EPS of $6.84, surpassing estimates, with revenues of $18.61 billion, a year-over-year increase of 6.4%.
  • The company recently declared a quarterly dividend of $0.72 per share, with a dividend yield of 0.7%, scheduled for payment on September 30th.
  • MarketBeat previews top five stocks to own in October.

Livforsakringsbolaget Skandia Omsesidigt lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 27.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,999 shares of the company's stock after buying an additional 4,800 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt's holdings in HCA Healthcare were worth $8,419,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Price T Rowe Associates Inc. MD lifted its holdings in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after acquiring an additional 587,036 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after acquiring an additional 1,699,713 shares during the period. Nuveen LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at $569,217,000. Finally, Pacer Advisors Inc. lifted its position in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after acquiring an additional 1,329,618 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HCA. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Bank of America upped their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Robert W. Baird upped their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $407.75.

Get Our Latest Research Report on HCA

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA stock traded up $1.00 during midday trading on Friday, hitting $402.06. The company had a trading volume of 4,308,470 shares, compared to its average volume of 1,077,287. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98. The stock has a market cap of $94.08 billion, a price-to-earnings ratio of 16.90, a PEG ratio of 1.27 and a beta of 1.41. The company's 50 day simple moving average is $385.21 and its 200 day simple moving average is $366.09. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.